CEBPB and glioblastoma: Clinically, simultaneous high expression of CEBPB, SPP1, and Integrin αvβ1 not only leads to a high enrichment of M2 TAMs in GBM tissues but also significantly shortens the lifespan of GBM patients (Figure 8N-O, Figure S15D-E).